Peter C. Farrell, Director at Resmed, holds 157.40K shares in Resmed (Ticker: RMD), holds 53.17K shares in Evolus (Ticker: EOLS), holds 95.56K shares in Arcturus Therapeutics (Ticker: ARCT). Most recently, Peter C. Farrell Sold ― shares of Resmed on Feb 23, 2024 for an estimated value of 4.99M.